Your browser doesn't support javascript.
loading
Recurrent infection progressively disables host protection against intestinal inflammation.
Yang, Won Ho; Heithoff, Douglas M; Aziz, Peter V; Sperandio, Markus; Nizet, Victor; Mahan, Michael J; Marth, Jamey D.
Afiliação
  • Yang WH; Center for Nanomedicine, University of California, Santa Barbara, Santa Barbara, CA 93106, USA.
  • Heithoff DM; Sanford Burnham Prebys Medical Discovery Institute, University of California, Santa Barbara, Santa Barbara, CA 93106, USA.
  • Aziz PV; Department of Molecular, Cellular, and Developmental Biology, University of California, Santa Barbara, Santa Barbara, CA 93106, USA.
  • Sperandio M; Center for Nanomedicine, University of California, Santa Barbara, Santa Barbara, CA 93106, USA.
  • Nizet V; Department of Molecular, Cellular, and Developmental Biology, University of California, Santa Barbara, Santa Barbara, CA 93106, USA.
  • Mahan MJ; Center for Nanomedicine, University of California, Santa Barbara, Santa Barbara, CA 93106, USA.
  • Marth JD; Sanford Burnham Prebys Medical Discovery Institute, University of California, Santa Barbara, Santa Barbara, CA 93106, USA.
Science ; 358(6370)2017 12 22.
Article em En | MEDLINE | ID: mdl-29269445
ABSTRACT
Intestinal inflammation is the central pathological feature of colitis and the inflammatory bowel diseases. These syndromes arise from unidentified environmental factors. We found that recurrent nonlethal gastric infections of Gram-negative Salmonella enterica Typhimurium (ST), a major source of human food poisoning, caused inflammation of murine intestinal tissue, predominantly the colon, which persisted after pathogen clearance and irreversibly escalated in severity with repeated infections. ST progressively disabled a host mechanism of protection by inducing endogenous neuraminidase activity, which accelerated the molecular aging and clearance of intestinal alkaline phosphatase (IAP). Disease was linked to a Toll-like receptor 4 (TLR4)-dependent mechanism of IAP desialylation with accumulation of the IAP substrate and TLR4 ligand, lipopolysaccharide-phosphate. The administration of IAP or the antiviral neuraminidase inhibitor zanamivir was therapeutic by maintaining IAP abundance and function.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Intoxicação Alimentar por Salmonella / Salmonella typhimurium / Doenças Inflamatórias Intestinais / Colo / Fosfatase Alcalina / Receptor 4 Toll-Like Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Intoxicação Alimentar por Salmonella / Salmonella typhimurium / Doenças Inflamatórias Intestinais / Colo / Fosfatase Alcalina / Receptor 4 Toll-Like Idioma: En Ano de publicação: 2017 Tipo de documento: Article